Linda Lennox - Lantheus Holdings VP Staff
| LNTH Stock | USD 92.79 0.26 0.28% |
Insider
Linda Lennox is VP Staff of Lantheus Holdings
| Age | 59 |
| Phone | 978 671 8001 |
| Web | https://www.lantheus.com |
Lantheus Holdings Management Efficiency
The company has return on total asset (ROA) of 0.17 % which means that it generated a profit of $0.17 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4553 %, meaning that it created $0.4553 on every $100 dollars invested by stockholders. Lantheus Holdings' management efficiency ratios could be used to measure how well Lantheus Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Deepak MBA | Dr Reddys Laboratories | 50 | |
| Reem Malki | Alvotech Warrant | 53 | |
| Peter Langosh | Amphastar P | 71 | |
| Sigridur Gudlaugsdottir | Alvotech Warrant | N/A | |
| Roy MD | Pacira BioSciences, | 62 | |
| Joseph McClellan | Alvotech Warrant | 51 | |
| Eiry MD | Neurocrine Biosciences | 61 | |
| Nicole Arndt | Dynavax Technologies | N/A | |
| Mark Levick | Alvotech Warrant | 60 | |
| Robyn Hunter | Journey Medical Corp | N/A | |
| Jonathan MD | Pacira BioSciences, | 50 | |
| Richard Kim | Avadel Pharmaceuticals PLC | 56 | |
| Jordan MD | Avadel Pharmaceuticals PLC | 47 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Ming Li | Alvotech Warrant | 48 | |
| Sravan Emany | Ironwood Pharmaceuticals | 46 | |
| Ziping Luo | Amphastar P | 75 | |
| Mukesh Rathi | Dr Reddys Laboratories | 45 | |
| K Singh | Dr Reddys Laboratories | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Daryl Gaugler | Pacira BioSciences, | 63 | |
Management Performance
| Return On Equity | 0.46 | ||||
| Return On Asset | 0.17 |
Lantheus Holdings Leadership Team
Elected by the shareholders, the Lantheus Holdings' board of directors comprises two types of representatives: Lantheus Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lantheus. The board's role is to monitor Lantheus Holdings' management team and ensure that shareholders' interests are well served. Lantheus Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lantheus Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lee Howe, Chief Officer | ||
| Daniel Niedzwiecki, General Officer | ||
| Dorothy Barr, Senior Operations | ||
| Paul Blanchfield, Chief Officer | ||
| Amanda Morgan, Senior Commercial | ||
| Etienne Montagut, Senior Vice President - Corporate Development | ||
| Carol Walker, Vice President | ||
| Brian Markison, Non-Executive Independent Chairman | ||
| Mark Kinarney, Director Relations | ||
| CFA Marshall, Chief Officer | ||
| Jamie Spaeth, Chief Officer | ||
| Melissa Downs, Director Communications | ||
| Linda Lennox, VP Staff | ||
| Mary Heino, CEO and President and Director | ||
| JeanClaude MD, Chief Officer | ||
| Andrea Sabens, Chief Officer | ||
| Kimberly Brown, Chief Officer |
Lantheus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lantheus Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.46 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 6.2 B | ||||
| Shares Outstanding | 69.53 M | ||||
| Shares Owned By Insiders | 2.49 % | ||||
| Shares Owned By Institutions | 97.51 % | ||||
| Number Of Shares Shorted | 6.62 M | ||||
| Price To Earning | 36.43 X |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantheus Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more detail on how to invest in Lantheus Stock please use our How to Invest in Lantheus Holdings guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantheus Holdings. If investors know Lantheus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantheus Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lantheus Holdings is measured differently than its book value, which is the value of Lantheus that is recorded on the company's balance sheet. Investors also form their own opinion of Lantheus Holdings' value that differs from its market value or its book value, called intrinsic value, which is Lantheus Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantheus Holdings' market value can be influenced by many factors that don't directly affect Lantheus Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantheus Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantheus Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantheus Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.